Protection by L-2-oxothiazolidine-4-carboxylic acid of hydrogen peroxide-induced CD3ζ and CD16ζ chain down-regulation in human peripheral blood lymphocytes and lymphokine-activated killer cells

Biochemical Pharmacology

Volumn 56, Issue 5, 1998, Pages 657-662

  Corsi, Massimiliano M ^a,b   Maes, Hubert H ^c   Wasserman, Ken ^d   Fulgenzi, Alessandro ^a   Gaja, Gianfranco ^a,b   Ferrero, Maria Elena ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b Ctro Stud Sulla Patol Cell CN   (Italy)

^c International Institute of Cellular and Molecular Pathology   (Belgium)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

chain; Hydrogen peroxide; L 2 oxothiazolidine 4 carboxylic acid; Lymphokine activated killer cells; Macrophages; Peripheral blood lymphocytes

Indexed keywords

2 OXO 4 THIAZOLIDINECARBOXYLIC ACID; GLUTATHIONE; HYDROGEN PEROXIDE;

ARTICLE; BLOOD; CARCINOGENESIS; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIGENS, CD3; CYTOPROTECTION; DOWN-REGULATION; HUMANS; HYDROGEN PEROXIDE; KILLER CELLS, LYMPHOKINE-ACTIVATED; LIPOPOLYSACCHARIDES; LYMPHOCYTES; MONOCYTES; PYRROLIDONECARBOXYLIC ACID; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IGG; SIGNAL TRANSDUCTION; THIAZOLES; THIAZOLIDINES;

EID: 18144449536     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00085-9     Document Type: Article

References (21)

1. Mizoguchi H., O'Shea J.J., Longo D.L., Loeffler C.M., McVicar D.W., Ochoa A.C. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science. 258:1992;1795-1798.
2. Aoe T., Okamoto Y., Saito T. Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J Exp Med. 181:1995;1881-1886.
3. lck in T-cells infiltrating human renal cell carcinoma. Cancer Res. 53:1993;5613-5616.
4. Gunji Y., Hori S., Aoe T., Asano T., Ochiai T., Isono K., Saito T. High frequency of cancer patients with abnormal assembly of the T-cell receptor-CD3 complex in peripheral blood T lymphocytes. Jpn J Cancer Res. 85:1994;1189-1192.
5. Matsuda M., Petersson M., Lenkei R., Taupin J.L., Magnusson I., Mellstedt H., Anderson P., Kiessling R. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: Correlation with the stage of the disease. Int J Cancer. 61:1995;765-772.
6. Kono K., Ressing M.E., Brandt P.M.R., Melief J.M.C., Potkul K.R., Andersson B., Petersson M., Kast M.W., Kiessling R. Decreased expression of signal-transducing ζ-chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin Canc Res. 2:1996;1825-1828.
7. Williamson J.M., Meister A. Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4-carboxylate, a 5-oxo-L-prolinase substrate. Proc Natl Acad Sci. 78:1981;936-939.
8. Martensson J., Jain A., Frayer W., Meister A. Glutathione metabolism in the lung: Inhibition of its synthesis leads to lamellar body and mitochondrial defects. Proc Natl Acad Sci. 86:1989;5296-5300.
9. Hirano T., Takeuchi S. Glutathione isopropyl ester (YM-737), a glutathione derivate, protects the exocrine pancreas in rats with cerulein-induced pancreatitis. Med Sci Res. 21:1993;915-916.
10. Anderson M.E., Naganuma A., Meister A. Protection against cisplatin toxicity by administration of glutathione ester. FASEB J. 4:1990;3251-3255.
11. Van Der Werf P., Orlowski K.I., Meister A. Enzymatic conversion of 5-oxo-L-proline (L-pyrrolidone carboxylate) to L-glutamate coupled with cleavage of adenosine triphosphate to adenosine diphosphate, a reaction in the g-glutamyl cycle. Proc Natl Acad Sci. 68:1971;2982-2985.
12. Williamson J.M., Boettcher B., Meister A. Intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis. Proc Natl Acad Sci. 79:1982;6246-6249.
13. Remacle J., Raes M., Toussaint O., Renard P., Rao G. Low levels of reactive oxygen species as modulators of cell function. Mutation Res. 316:1995;103-110.
14. Arrick B.A., Nathan C.F. Glutathione metabolism as a determinant of therapeutic efficacy: A review. Cancer Res. 44:1984;4224-4232.
15. Kono K., Salazar-Onfray F., Petersson M., Hansson J., Masucci G., Wasserman K., Nakazawa T., Anderson P., Kiessling R. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T-cell and natural killer cell-mediated cytotoxicity. Eur J Immunol. 26:1996;1308-1313.
16. Sagone A.L., Husney R., Guter H., Clark L. Effect of catalase on the proliferation of human lymphocytes to phorbol myristate acetate. J Immunol. 133:1984;1488-1494.
17. Meister A. Selective modification of glutathione metabolism. Science. 220:1983;472-477.
18. Staal F.J.T., Roederer M., Herzenberg L.A. Glutathione and immunophenotypes of T and B lymphocytes in HIV-infected individuals. Ann NY Acad Sci. 651:1992;453-463.
19. Noda I., Fujieda S., Saito H., Tanaka N., Sugimoto C., Hoshino T., Yagita M. Relationship between cellular glutathione level and susceptibility to LAK killing in a human pharyngeal carcinoma cell line. Anticancer Res. 14:1994;1117-1120.
20. Meister A., Anderson M.E. Glutathione. Annu Rev Biochem. 52:1983;711-760.
21. Porta P., Aebi S., Summer K., Lauterburg B.H. L-2-oxthiazolidine-4-carboxylic acid, a cysteine prodrug: pharmacokinetics and effects on thiols in plasma and lymphocytes in human. J Pharmacol Exp Ther. 257:1991;331-334.